KPC Pharmaceuticals's Nine-Month Profit Rises Slightly

MT Newswires Live

2024/10/28

KPC Pharmaceuticals (SHA:600422) saw its net profit decline to 390.5 million yuan in the nine months ended Sept. 30 from 396.2 million yuan a year prior, parent China Resources Pharmaceutical Group (HKG:3320) said in an Oct. 25 bourse filing.

The drugmaker's revenue for the period fell to 5.46 billion yuan from 5.61 billion yuan in the year-ago period.

Shares of KPC Pharmaceuticals closed over 6% higher on Monday.

Price (HKD): $15.45, Change: $+0.94, Percent Change: +6.48%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2478012861"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2478012861\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2478012861?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-28 19:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2478012861","market":"hk","top_or_hot":-1,"title":"KPC Pharmaceuticals's Nine-Month Profit Rises Slightly","media":"MT Newswires Live","content":"<html><body><p> KPC Pharmaceuticals (SHA:600422) saw its net profit decline to 390.5 million yuan in the nine months ended Sept. 30 from 396.2 million yuan a year prior, parent China Resources Pharmaceutical Group (HKG:3320) said in an Oct. 25 bourse filing.</p><p>The drugmaker's revenue for the period fell to 5.46 billion yuan from 5.61 billion yuan in the year-ago period.</p><p>Shares of KPC Pharmaceuticals closed over 6% higher on Monday.</p><p>Price (HKD): $15.45, Change: $+0.94, Percent Change: +6.48%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>KPC Pharmaceuticals's Nine-Month Profit Rises Slightly</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKPC Pharmaceuticals's Nine-Month Profit Rises Slightly\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2024-10-28 19:58</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> KPC Pharmaceuticals (SHA:600422) saw its net profit decline to 390.5 million yuan in the nine months ended Sept. 30 from 396.2 million yuan a year prior, parent China Resources Pharmaceutical Group (HKG:3320) said in an Oct. 25 bourse filing.</p><p>The drugmaker's revenue for the period fell to 5.46 billion yuan from 5.61 billion yuan in the year-ago period.</p><p>Shares of KPC Pharmaceuticals closed over 6% higher on Monday.</p><p>Price (HKD): $15.45, Change: $+0.94, Percent Change: +6.48%</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"孖展沽空","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2478012861","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478012861","pubTimestamp":1730116691,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"KPC Pharmaceuticals  saw its net profit decline to 390.5 million yuan in the nine months ended Sept. 30 from 396.2 million yuan a year prior, parent China Resources Pharmaceutical Group  said in an Oct. 25 bourse filing.The drugmaker's revenue for the period fell to 5.46 billion yuan from 5.61 billion yuan in the year-ago period.Shares of KPC Pharmaceuticals closed over 6% higher on Monday.Price : $15.45, Change: $+0.94, Percent Change: +6.48%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600422":"昆药集团","BK0188":"融资融券","BK1191":"制药","BK4588":"碎股","BK4526":"热门中概股","BK1570":"华润系","BK4585":"ETF&股票定投概念","BK4023":"应用软件","BK0060":"抗癌","BK0028":"国家队","BK0239":"医药制造","HKD":"尚乘数科","03320":"华润医药"},"translate_title":"KPC Pharmaceuticals九个月利润小幅增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600422":0.9,"03320":0.9,"HKD":1},"content_text":"KPC Pharmaceuticals (SHA:600422) saw its net profit decline to 390.5 million yuan in the nine months ended Sept. 30 from 396.2 million yuan a year prior, parent China Resources Pharmaceutical Group (HKG:3320) said in an Oct. 25 bourse filing.The drugmaker's revenue for the period fell to 5.46 billion yuan from 5.61 billion yuan in the year-ago period.Shares of KPC Pharmaceuticals closed over 6% higher on Monday.Price (HKD): $15.45, Change: $+0.94, Percent Change: +6.48%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}